Key result
Lower extremity bypass by vascular surgeons vs non-vascular surgeons reduced 30-day major amputation in CLTI (3.0% vs 7.5%; aOR 0.46; 95% CI 0.29-0.72; p<0.01).
Why the study?
Does lower extremity bypass performed by board-certified vascular surgeons reduce 30-day major amputation compared to non-vascular surgeons in patients with chronic limb-threatening ischemia?
Cohort
Yes
Does lower extremity bypass performed by board-certified vascular surgeons reduce 30-day major amputation compared to non-vascular surgeons in patients with chronic limb-threatening ischemia?
Answers are grounded in this paper and cite their sources.
Patients with chronic limb-threatening ischemia undergoing lower extremity bypass have significantly lower 30-day major amputation rates when operated on by board-certified vascular surgeons compared to non-vascular surgeons, even after adjusting for operation type and conduit usage.
Background While the treatment of peripheral artery disease with lower extremity bypass is performed primarily by board-certified vascular surgeons, a subset of non-vascular surgeons continues performing these cases. We investigated differences in practice patterns and surgical outcomes between vascular and non-vascular surgeons for bypass in patients with claudication and chronic limb-threatening ischemia (CLTI). Methods The ACS-NSQIP targeted database from 2011 to 2022 was used to select non-emergent claudication and CLTI patients. Propensity matching (3:1) was applied to balance demographics and comorbidities between vascular and non-vascular surgeons. Claudication and CLTI cohorts were analyzed separately. Thirty-day outcomes were examined. Results Femoropopliteal bypass was the most common procedure followed by femoral-distal bypass for both vascular and non-vascular surgeons. Vascular surgeons were more likely to perform femoral-distal procedures and use single-segment saphenous vein grafts (SSSV) for both claudication and CLTI. Vascular surgeons were less likely to use other non-SSSV conduits for claudication patients (40.6% vs 54.6%, p < 0.01), but no difference in CLTI (38.9%% vs 40.1%, p = 0.74). There was no significant difference in 30-day mortality/morbidities between surgeons for either claudication or CLTI. However, 30-day major amputation for CLTI was significantly better with vascular surgeons (3.0% vs 7.5%, p < 0.01). In CLTI patients, after correcting for operation type and conduit usage, vascular surgeons continued to be associated with lower major amputation (aOR = 0.46, 95 CI = 0.29–0.72, p < 0.01). Conclusion Vascular surgeons have better limb salvage than non-vascular surgeons. This could not be explained by the higher use of SSSV; thus, other factors such as surgical skill may account for better outcomes.
No takes yet. Share an insight, caveat, or question.
Recarey et al. (2026) conducted a cohort in Peripheral artery disease (claudication and chronic limb-threatening ischemia). Lower extremity bypass performed by board-certified vascular surgeons vs. Lower extremity bypass performed by non-vascular surgeons was evaluated on 30-day major amputation in chronic limb-threatening ischemia (CLTI) patients (aOR 0.46, 95% CI 0.29-0.72, p=<0.01). Lower extremity bypass by vascular surgeons vs non-vascular surgeons reduced 30-day major amputation in CLTI (3.0% vs 7.5%; aOR 0.46; 95% CI 0.29-0.72; p<0.01).
Synapse has enriched 10 related papers. Consider them for comparative context: